Related Experiment Video
Updated: Jun 20, 2026
14:34
A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English
Published on: April 3, 2026
Polo-like kinases mediate cell survival in mitochondrial dysfunction.
Takumi Matsumoto1, Ping-Yuan Wang, Wenzhe Ma
1Translational Medicine Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Summary
Targeted ablation of mitochondrial respiration increases Polo-like kinase 2 (PLK2) expression, which is essential for cancer cell survival. PLK2 activity is necessary for the growth of cancer cells with compromised respiration, indicating a critical cell cycle pathway.
Area of Science:
- Cell Biology
- Cancer Biology
- Metabolic Pathways
Background:
- Cancer cells frequently exhibit impaired mitochondrial respiration, creating a metabolic vulnerability.
- Understanding survival pathways in these cells is crucial for developing novel cancer therapies.
Purpose of the Study:
- To investigate the role of Polo-like kinase 2 (PLK2) in cancer cell survival under conditions of mitochondrial dysfunction.
- To identify the specific mechanisms by which PLK2 promotes the growth of non-respiring cancer cells.
Main Methods:
- Targeted ablation of mitochondrial respiration in cancer cell lines.
- Analysis of Polo-like kinase 2 (PLK2) expression levels.
- In vitro and in vivo studies using xenograft models to assess the necessity of PLK2.
- Identification of PLK2's kinase activity through phosphorylation site analysis.
Main Results:
- Ablation of mitochondrial respiration significantly upregulates PLK2 expression.
- PLK2 is required for the in vitro proliferation of cancer cells with impaired respiration.
- PLK2 phosphorylates Ser-137 of PLK1, mediating a critical survival signal.
- PLK2 knockdown abrogates xenograft formation in vivo, confirming its necessity for tumor growth in cells with compromised respiration.
Conclusions:
- PLK2 is a key mediator of cancer cell survival under conditions of mitochondrial respiratory defects.
- PLK2 acts through phosphorylation of PLK1 to promote cell cycle progression in metabolically stressed cancer cells.
- Targeting the PLK2-PLK1 axis represents a potential therapeutic strategy for cancers with mitochondrial dysfunction.
More Related Videos
Related Concept Videos
01:22PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...
01:45Mitochondrial Membranes
A single mitochondrion is a bean-shaped organelle enclosed by a double-membrane system. The outer membrane of mitochondria is smooth and contains many porins - the integral membrane transporters. Porins enable free diffusion of ions and small uncharged molecules through the outer mitochondrial membrane but limit the transport of molecules larger than 5000 Daltons. Further, the outer mitochondrial membrane forms a unique structure called membrane contact sites with other subcellular organelles,...
01:46Electron Transport Chain: Complex I and II
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
01:19Translocation of Proteins into the Mitochondria
Mitochondrial precursors are translocated to the internal subcompartments via independent mechanisms involving distinct protein machineries called translocases.
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...